Natural Alternatives
This article was originally published in The Tan Sheet
Executive Summary
San Marcos, Calif.-based supplement firm's net sales increased 45% to $23.3 mil. in the fiscal fourth quarter (ended June 30). For the year, net sales totalled $78.5 mil., up 40%, and income jumped to $3 mil, up 171%. Year-end results for the fiscal year included a 50% increase in private label contract manufacturing sales. Natural Alternatives "invested heavily" in facilities and equipment in fiscal 2004 and "will continue those investments in fiscal 2005," according to President Randell Weaver...
You may also be interested in...
Natural Alternatives
San Marcos, Calif.-based supplement firm reports sales increase of 36% to $22.7 mil. with earnings up 50% to $852,000 in the first fiscal quarter. CEO Mark Le Doux said sales are in line with fiscal 2005 growth plans, and that Natural Alternatives is "beginning to see brand preference develop" in its contract manufacturing business. In its last earnings call, the firm maintained it will continue investments in facilities and equipment throughout the fiscal year (1"The Tan Sheet" Sept. 29, 2004, In Brief)...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.